Guggenheim Capital LLC increased its holdings in Cerner Co. (NASDAQ:CERN) by 25.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,121,984 shares of the company’s stock after buying an additional 227,626 shares during the period. Guggenheim Capital LLC owned about 0.34% of Cerner worth $75,611,000 as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in the business. Icon Wealth Partners LLC acquired a new position in shares of Cerner during the 4th quarter valued at about $107,000. Fuller & Thaler Asset Management Inc. acquired a new stake in Cerner during the 3rd quarter worth approximately $121,000. Cerebellum GP LLC acquired a new stake in Cerner during the 4th quarter worth approximately $127,000. Steward Partners Investment Advisory LLC acquired a new stake in Cerner during the 3rd quarter worth approximately $128,000. Finally, Delpha Capital Management LLC acquired a new stake in Cerner during the 4th quarter worth approximately $144,000. Institutional investors own 78.56% of the company’s stock.
In related news, Director William D. Zollars sold 4,100 shares of the firm’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $62.16, for a total transaction of $254,856.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, President Zane M. Burke sold 50,000 shares of the firm’s stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $70.00, for a total value of $3,500,000.00. The disclosure for this sale can be found here. Insiders have sold 595,800 shares of company stock worth $38,133,420 over the last 90 days. 13.11% of the stock is currently owned by company insiders.
Cerner Co. (CERN) opened at $64.91 on Monday. The company has a market capitalization of $21,588.89, a P/E ratio of 29.24, a PEG ratio of 1.89 and a beta of 0.93. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.99 and a current ratio of 3.01. Cerner Co. has a one year low of $54.49 and a one year high of $73.86.
Cerner (NASDAQ:CERN) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.61 by ($0.03). Cerner had a return on equity of 16.82% and a net margin of 16.86%. The firm had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter last year, the business earned $0.61 earnings per share. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. sell-side analysts anticipate that Cerner Co. will post 2.42 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “Guggenheim Capital LLC Acquires 227,626 Shares of Cerner Co. (CERN)” was first posted by American Banking News and is the property of of American Banking News. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/03/12/guggenheim-capital-llc-acquires-227626-shares-of-cerner-co-cern.html.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.